Myeloid Cell Mediated Immune Suppression in Pancreatic CancerSummary

Pancreatic ductal adenocarcinoma (PDA), the most common pancreatic cancer, is a nearly universally lethal malignancy. PDA is characterized by extensive infiltration of immunosuppressive myeloid cells, including tumor-associated macrophages and myeloid-derived suppressor cells. Myeloid cells in the t...

Full description

Saved in:
Bibliographic Details
Main Authors: Samantha B. Kemp, Marina Pasca di Magliano, Howard C. Crawford
Format: article
Language:EN
Published: Elsevier 2021
Subjects:
Online Access:https://doaj.org/article/c6ea5886473b4e40acf34f6c756e6adf
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:doaj.org-article:c6ea5886473b4e40acf34f6c756e6adf
record_format dspace
spelling oai:doaj.org-article:c6ea5886473b4e40acf34f6c756e6adf2021-11-12T04:38:59ZMyeloid Cell Mediated Immune Suppression in Pancreatic CancerSummary2352-345X10.1016/j.jcmgh.2021.07.006https://doaj.org/article/c6ea5886473b4e40acf34f6c756e6adf2021-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352345X2100151Xhttps://doaj.org/toc/2352-345XPancreatic ductal adenocarcinoma (PDA), the most common pancreatic cancer, is a nearly universally lethal malignancy. PDA is characterized by extensive infiltration of immunosuppressive myeloid cells, including tumor-associated macrophages and myeloid-derived suppressor cells. Myeloid cells in the tumor microenvironment inhibit cytotoxic T-cell responses promoting carcinogenesis. Immune checkpoint therapy has not been effective in PDA, most likely because of this robust immune suppression, making it critical to elucidate mechanisms behind this phenomenon. Here, we review myeloid cell infiltration and cellular crosstalk in PDA progression and highlight current therapeutic approaches to target myeloid cell-driven immune suppression.Samantha B. KempMarina Pasca di MaglianoHoward C. CrawfordElsevierarticleDiseases of the digestive system. GastroenterologyRC799-869ENCellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 5, Pp 1531-1542 (2021)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the digestive system. Gastroenterology
RC799-869
spellingShingle Diseases of the digestive system. Gastroenterology
RC799-869
Samantha B. Kemp
Marina Pasca di Magliano
Howard C. Crawford
Myeloid Cell Mediated Immune Suppression in Pancreatic CancerSummary
description Pancreatic ductal adenocarcinoma (PDA), the most common pancreatic cancer, is a nearly universally lethal malignancy. PDA is characterized by extensive infiltration of immunosuppressive myeloid cells, including tumor-associated macrophages and myeloid-derived suppressor cells. Myeloid cells in the tumor microenvironment inhibit cytotoxic T-cell responses promoting carcinogenesis. Immune checkpoint therapy has not been effective in PDA, most likely because of this robust immune suppression, making it critical to elucidate mechanisms behind this phenomenon. Here, we review myeloid cell infiltration and cellular crosstalk in PDA progression and highlight current therapeutic approaches to target myeloid cell-driven immune suppression.
format article
author Samantha B. Kemp
Marina Pasca di Magliano
Howard C. Crawford
author_facet Samantha B. Kemp
Marina Pasca di Magliano
Howard C. Crawford
author_sort Samantha B. Kemp
title Myeloid Cell Mediated Immune Suppression in Pancreatic CancerSummary
title_short Myeloid Cell Mediated Immune Suppression in Pancreatic CancerSummary
title_full Myeloid Cell Mediated Immune Suppression in Pancreatic CancerSummary
title_fullStr Myeloid Cell Mediated Immune Suppression in Pancreatic CancerSummary
title_full_unstemmed Myeloid Cell Mediated Immune Suppression in Pancreatic CancerSummary
title_sort myeloid cell mediated immune suppression in pancreatic cancersummary
publisher Elsevier
publishDate 2021
url https://doaj.org/article/c6ea5886473b4e40acf34f6c756e6adf
work_keys_str_mv AT samanthabkemp myeloidcellmediatedimmunesuppressioninpancreaticcancersummary
AT marinapascadimagliano myeloidcellmediatedimmunesuppressioninpancreaticcancersummary
AT howardccrawford myeloidcellmediatedimmunesuppressioninpancreaticcancersummary
_version_ 1718431257232146432